Long term follow-up of patients with patent ductus arteriosus after transcatheter closure

被引:3
作者
Peng, Yue [1 ,2 ]
Cheng, Zhenli [1 ,2 ]
Zhang, Yan [3 ]
Yi, Qijian [1 ,2 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Dept Cardiovasc Med, Natl Clin Res Ctr Child Hlth & Disorders,Minist Ed, Chongqing 400014, Peoples R China
[2] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China
[3] Sichuan Prov Matern & Child Hlth Care Hosp, Dept Pediat Heart Ctr, Chengdu 610000, Peoples R China
关键词
SCIENTIFIC STATEMENT; COMPLICATIONS; OCCLUSION; OCCLUDER; CHILDREN;
D O I
10.1038/s41390-024-03317-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundTo investigate the concurrent, long-term, and future adverse events and assess the trend of adverse events in pediatric patients with patent ductus arteriosus (PDA) after transcatheter closure.MethodsA total of 1590 patients underwent transcatheter PDA closure were enrolled, including 465 patients (median age = 22 months) in the training group and 1125 patients in the validation group. Logistic regression analysis was used to assess independent risk factors associated with concurrent adverse events after closure. The chi-square test was used to evaluate the 5-year follow-up trend.ResultsMultivariable logistic regression analysis indicated that low age, female, and high pulmonary end diameter were independent risk factors for concurrent adverse events after closure. For patients without concurrent adverse events and for those who with concurrent adverse events but return to normal, the Chi-square test showed no abnormal results at the 5-year follow-up. Furthermore, the follow-up data of the validation group were not significantly different from those of the training group.ConclusionThe value of long-term follow-up of children may be limited for those who did not have a concurrent adverse event after closure nor for those who had a concurrent adverse event after closure but returned to normal during the 5-year follow-up period.ImpactFollow-up monitoring of adverse events tended to be recommended in pediatric patients with PDA after transcatheter closure. However, follow-up in these pediatric patients is expensive and there is a risk of sedation for echocardiography examination frequently.<middle dot>Patients who had no concurrent adverse events after closure did not show any abnormality at 5-year follow-up.<middle dot>Most of the patients who had concurrent adverse events after closure returned to normal at 5-year follow-up.The value of long-term follow-up may be limited for the above patients after transcatheter PDA closure.
引用
收藏
页码:1122 / 1126
页数:5
相关论文
共 21 条
[1]   Hemolysis and its outcome following percutaneous closure of cardiac defects among children and adolescents: a prospective study [J].
Amoozgar, Hamid ;
Soltani, Romeileh ;
Edraki, Mohammadreza ;
Mehdizadegan, Nima ;
Mohammadi, Hamid ;
Ajami, Gholamhossein ;
Borzouee, Mohammad ;
Naghshzan, Amir ;
Keshavarz, Kambiz .
ITALIAN JOURNAL OF PEDIATRICS, 2019, 45 (01)
[2]   Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider [J].
Backes, Carl H. ;
Hill, Kevin D. ;
Shelton, Elaine L. ;
Slaughter, Jonathan L. ;
Lewis, Tamorah R. ;
Weisz, Dany E. ;
Mah, May Ling ;
Bhombal, Shazia ;
Smith, Charles, V ;
McNamara, Patrick J. ;
Benitz, William E. ;
Garg, Vidu .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (17)
[3]   Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association [J].
Baddour, Larry M. ;
Wilson, Walter R. ;
Bayer, Arnold S. ;
Fowler, Vance G., Jr. ;
Tleyjeh, Imad M. ;
Rybak, Michael J. ;
Barsic, Bruno ;
Lockhart, Peter B. ;
Gewitz, Michael H. ;
Levison, Matthew E. ;
Bolger, Ann F. ;
Steckelberg, James M. ;
Baltimore, Robert S. ;
Fink, Anne M. ;
O'Gara, Patrick ;
Taubert, Kathryn A. .
CIRCULATION, 2015, 132 (15) :1435-1486
[4]   ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) [J].
Baumgartner, Helmut ;
Bonhoeffer, Philipp ;
De Groot, Natasja M. S. ;
de Haan, Fokko ;
Deanfield, John Erik ;
Galie, Nazzareno ;
Gatzoulis, Michael A. ;
Gohlke-Baerwolf, Christa ;
Kaemmerer, Harald ;
Kilner, Philip ;
Meijboom, Folkert ;
Mulder, Barbara J. M. ;
Oechslin, Erwin ;
Oliver, Jose M. ;
Serraf, Alain ;
Szatmari, Andras ;
Thaulow, Erik ;
Vouhe, Pascal R. ;
Walma, Edmond .
EUROPEAN HEART JOURNAL, 2010, 31 (23) :2915-2957
[5]   Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension: Short and intermediate term results [J].
Bhalgat, Parag S. ;
Pinto, Robin ;
Dalvi, Bharat V. .
ANNALS OF PEDIATRIC CARDIOLOGY, 2012, 5 (02) :135-140
[6]   The Amplatzer duct occluder: Experience in 209 patients [J].
Bilkis, AA ;
Alwi, M ;
Hasri, S ;
Haifa, AL ;
Geetha, K ;
Rehman, MA ;
Hasanah, I .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :258-261
[7]   Percutaneous Closure of the Patent Ductus Arteriosus in Infants ≤2 kg: IMPACT Registry Insights [J].
Bischoff, Adrianne Rahde ;
Kennedy, Kevin F. ;
Backes, Carl H. ;
Sathanandam, Shyam ;
McNamara, Patrick J. .
PEDIATRICS, 2023, 152 (03)
[8]  
Boehm W, 2007, Images Paediatr Cardiol, V9, P16
[9]   A novel biodegradable occluder for the closure of ventricular septal defects: immediate and medium-term results in a canine model [J].
Bu, Haisong ;
Yang, Yifeng ;
Hu, Shijun ;
Wu, Qin ;
Gong, Xueyang ;
Zhao, Tianli .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 29 (05) :783-792
[10]   Safety of Percutaneous Patent Ductus Arteriosus Closure: An Unselected Multicenter Population Experience [J].
El-Said, Howaida G. ;
Bratincsak, Andras ;
Foerster, Susan R. ;
Murphy, Joshua J. ;
Vincent, Julie ;
Holzer, Ralf ;
Porras, Diego ;
Moore, John ;
Bergersen, Lisa .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (06) :e000424